INS and dementia: This paper determined that several factors were associated with alterations in the risk of developing dementia in patients with T2DM. The usage of glitazones, metformin, and SUs showed a decreased risk in comparison to insulin usage, which showed an increased risk. Moreover, higher HbA1c levels are also shown to be an additional risk factor for the development of dementia.